Dengue disease severity in Indonesian children: an evaluation of the World Health Organization classification system. by Setiati, T.E. et al.






The version of the following full text has not yet been defined or was untraceable and may
differ from the publisher's version.
 
 





Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
BMC Infectious Diseases oBioMed Central
Research article
Dengue disease severity in Indonesian children: an evaluation of the 
W orld Health Organization classification system
Tatty E Setiati1, Albert TA M airuhu*2, Penelopie Koraka3,
M oham ed Supriatna1, Melvin R Mac Gillavry2, Dees PM Brandjes2,
Albert DME Osterhaus3, Jos WM van der Meer4, Eric CM van Gorp2 and 
Augustinus Soem antri1
Address: 'Department o f Child Health, Dr. Kariadi Hospital, Semarang, Indonesia, 2Department o f Internal Medicine, Slotervaart Hospital, 
Amsterdam, the Netherlands, 3Institute o f  Virology, Erasmus Medical Centre, Rotterdam, the Netherlands and 4Dept. o f Internal Medicine, 
University Medical Centre St. Radboud, Nijmegen, the Netherlands
Email: Tatty E Setiati - tatty@smg.melsa.net.id; Albert TA Mairuhu* - igrmr@slz.nl; Penelopie Koraka - Penelope.koraka@viroscope.com; 
Mohamed Supriatna - priandpri@yahoo.com; Melvin R Mac Gillavry - m.r.macgillavry@planet.nl; Dees PM Brandjes - liesned@worldonline.nl; 
Albert DME Osterhaus - a.osterhaus@erasmusmc.nl; Jos WM van der Meer - J.vanderMeer@AIG.umcn.nl; Eric CM van 
Gorp - ecmvangorp@yahoo.co.uk; Augustinus Soemantri - atamairuhu@hotmail.com
* Corresponding author
Open Access
Published: 26 March 2007 Received: 19 July 2006
BMC Infectious Diseases 2007, 7:22 doi:10.1186/1471-2334-7-22 Accepted: 26 March 2007
This article is available from: http://www.biomedcentral.com/1471-2334/7/22 
©  2007 Setiati et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: Dengue disease severity is usually classified using criteria set up by the World 
Health Organization (WHO). We aimed to assess the diagnostic accuracy of the WHO 
classification system and modifications to this system, and evaluated their potential practical 
usefulness.
Methods: Patients, admitted consecutively to the hospital with severe dengue, were classified 
using the WHO classification system and modifications to this system. Treating physicians were 
asked to classify patients immediately after discharge. We calculated the sensitivity of the various 
classification systems for the detection of shock and the agreement between the various 
classification systems and the treating physician's classification.
Results: Of 152 patients with confirmed dengue, sixty-six (43%) had evidence of circulatory failure. 
The W HO classification system had a sensitivity of 86% (95%CI 76-94) for the detection of patients 
with shock. All modifications to the WHO classification system had a higher sensitivity than the 
WHO classification system (sensitivity ranging from 88% to 99%). The W HO classification system 
was in only modest agreement with the intuitive classification by treating physicians whereas several 
modified classification systems were in good agreement.
Conclusion: The use of the WHO classification system to classify dengue disease severity is to be 
questioned, because it is not accurate in correctly classifying dengue disease severity and it lacks 
sufficient agreement with clinical practice.
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Background
Dengue virus infections are recognized as major public 
health problems in tropical and subtropical regions. Each 
year an estimated 100 million infections occur and 
between 250.000 and 500.000 severe cases are reported to 
the World Health Organization (WHO) [1]. Infection 
with any of the four dengue virus serotypes may give a 
broad spectrum of clinical manifestations ranging from 
no or minimal symptoms that cannot be easily distin­
guished clinically from other viral infections to a more 
severe form of disease that is characterized by a haemor- 
rhagic tendency and increased vascular permeability. The 
WHO set up a classification system to differentiate 
between the self-limiting though debilitating dengue fever 
(DF), and the potentially lethal dengue haemorrhagic 
fever (DHF) [2]. According to these criteria, DHF is 
defined by the presence of fever, a haemorrhagic ten­
dency, thrombocytopenia and some evidence of plasma 
leakage due to increased vascular permeability. DHF is 
further subdivided, with most severe cases categorized as 
dengue shock syndrome (DSS) when circulatory failure is 
present [2].
A standardized classification system for the severity of 
dengue virus infections is crucial for optimal communica­
tion of scientific data to improve our understanding of the 
pathogenesis and treatment of the disease. Incorrect dis­
ease severity classification may lead to faulty decision 
making in choosing the most appropriate treatment for 
the individual patient. Although the WHO classification 
system has been widely applied in research settings and 
publications, its use in everyday clinical practice has not 
proven easy or practical. In recent years, several studies 
reported difficulties with classification, inconsistencies in 
the WHO classification system and some found it neces­
sary to define new categories to identify severe cases that 
do not meet the criteria for DHF or DSS [3-9].
These findings raise the question if the current WHO clas­
sification system is appropriate for the classification of 
dengue disease severity. To answer this, we assessed the 
diagnostic accuracy of the WHO classification system and 
modifications to this system. The presence of shock was 
used as marker of disease severity. By comparing the vari­
ous classification systems with an intuitive classification 
done by treating physicians, we additionally evaluated the 
practical usefulness of the WHO classification system and 
the various modified classification systems.
Methods
Patients and clin ica l procedures
The study was conducted from February 2001 to April 
2003 on the paediatric intensive care unit and paediatric 
ward of the Dr. Kariadi Hospital in Semarang, Central 
Java, a region in Indonesia where dengue is endemic.
Patients, aged 2 to 14 years, consecutively admitted to the 
hospital with suspected severe dengue virus infection were 
included, provided that a parent or legal guardian gave 
informed consent. No strict criteria were used for inclu­
sion in the study. Treating physicians could use the WHO 
case definition for dengue haemorrhagic fever as a guiding 
principle. If patients did not meet all criteria bu t a clinical 
suspicion of severe dengue virus infection was present, 
these patients were still eligible for inclusion. Members of 
the study team recorded demographic data, medical his­
tory, physical examination findings, clinical course and 
routine laboratory test results for each patient on a stand­
ard data form. The tourniquet test was performed on 
admission. Since it may be negative when circulatory fail­
ure is present the test was repeated after recovery from 
shock. Platelet count was performed daily. Haematocrit 
was measured at admission, every 2 hours for the first 6 
hours and than every 6 hours until stable. Both haemat- 
ocrit and platelet count were repeated in the event of clin­
ical deterioration (i.e. recurrent shock, massive 
hemorrhage). Additional blood samples for diagnostic 
procedures were obtained on day of admission and on 
day 7 after enrolment. The ethics committee of the Dr. 
Kariadi Hospital approved all clinical and laboratory 
aspects of this study.
Classification o f  disease severity
The study was initially designed to study pathophysiolog­
ical mechanisms of hemorrhagic tendencies in patients 
with a severe dengue virus infection. For this we collected 
blood samples on several points in time during admission 
for the analysis of coagulation activity, fibrinolysis and 
inflammatory mediators. The study protocol and results 
of these studies have been described previously [10,11]. 
During the study, treating physicians were asked to clas­
sify patients as having DF, DHF or DSS immediately after 
patients were discharged. This intuitive classification was 
based on knowledge of medical history, physical exami­
nation findings, clinical course and all available results of 
routine tests (such as blood tests and chest X-ray). No 
structured algorithm was used to classify patients. The 
respective treating physicians were many different resi­
dents who worked under supervision of staff physicians at 
the paediatric intensive care unit and the paediatric ward 
of the Dr. Kariadi Hospital. Physicians were unaware of 
the fact that a structured classification was performed after 
completion of the study.
After completion of the study, two investigators (PK and 
ATAM) determined the presence of the following four 
clinical and laboratory manifestations on admission and 
during follow up in every patient using the standard data 
form: 1) fever or a history of acute fever, 2) haemorrhagic 
manifestations (at least a positive tourniquet test), 3) 
thrombocytopenia (platelet count < 100.000 cells/mm3),
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and 4) signs of plasma leakage using laboratory findings 
(haematocrit > 20% above average for age, haematocrit > 
20% compared to the haematocrit at hospital discharge, 
hypoproteinemia or hypoalbuminemia) and chest X-ray 
for the detection of pleural effusion. The presence of 
ascites on physical examination was not used as a sign of 
plasma leakage since routine physical examination has 
definite limitations in the precise diagnosis of ascites [12]. 
The determination of the presence of these manifestations 
was performed independently of each other and blind to 
the treating physician's classification. Disagreement was 
resolved by discussion and if necessary by adjudication of 
a third reviewer (E.C.M.v.G.).
Patients were subsequently classified as having DHF using 
these manifestations as proposed by the WHO [2]. If 
patients did no t have one or more of these manifestations, 
they were considered to suffer from DF. In addition, sev­
eral modifications to the WHO classification system were 
made as previously described [8]. Since all patients had 
fever or had a history of acute fever, the remaining three 
manifestations (haemorrhagic manifestations, throm bo­
cytopenia and signs of leakage) were used to make the 
modifications. This resulted in six modified classification 
systems (Table 1). DSS was diagnosed when all DHF cri­
teria were met plus evidence of circulatory failure defined 
as hypotension for age (systolic pressure <90 mmHg for 
those > 5 years of age and <80 mmHg for those <5 years 
of age) or narrow pulse pressure (<20 mmHg) [2].
Diagnostic procedures
Paired blood samples were tested for serologic evidence of 
acute dengue infection. Commercially available enzyme- 
linked immunosorbent assays (Focus Technologies, 
Cypress, Calif., USA) were used for the detection of den­
gue virus specific IgG and IgM antibodies, according to the 
procedures described by the manufacturer. The sensitivity 
and specificity of these tests have been evaluated previ­
ously [13]. Cases were considered serologically-confirmed 
if the IgM ELISA was positive during the acute phase of 
disease (optical density of the sample higher than the 
optical density of the cut off serum provided by the m an­
ufacturer) and/or if a four-fold increase in IgG titre was 
demonstrated in paired acute and convalescent sera. For 
some patients, a definitive serodiagnosis was not possible 
because no convalescent sample was obtained. Detection
of dengue virus antigen and/or viral RNA was attempted 
in these cases using a dot blot immunoassay and a dengue 
serotype specific reverse transcription PCR respectively 
[14]. Patients with definitive serodiagnosis and/or posi­
tive dot blot and/or positive PCR were considered to have 
confirmed dengue virus infection. The absence of dengue 
virus antigen, viral RNA and negative serology, was indic­
ative of a non-dengue virus infection. When an alternative 
clinical diagnosis was absent and serology was inconclu­
sive, patients were characterized as indeterminate.
Statistical analysis
The evaluation of the diagnostic accuracy of the various 
classification systems was based on the presence of circu­
latory failure on admission and during follow up as the 
"reference standard". We calculated the proportion of 
patients with circulatory failure who were correctly classi­
fied as DHF (sensitivity). In addition, we calculated the 
proportion of patients classified as DF by the WHO classi­
fication system and without circulatory failure who were 
reclassified as having DHF when the modified classifica­
tion systems were applied. The corresponding exact 95% 
confidence intervals (95% CI) were calculated from the 
binomial distribution.
As a measure of agreement between various classifications 
systems and the intuitive classification by the treating 
physician, we calculated the weighted kappa ( k w)  statistic 
with a 95% confidence interval. The k w values were inter­
preted as: poor agreement, < 0.20; fair agreement, 0.21 to 
0.40; moderate agreement, 0.41 to 0.60; good agreement, 
0.61 to 0.80; or very good agreement, > 0.81 [15]. A P- 
value < 0.05 was considered to indicate statistical signifi­
cance. Analyses were performed using SPSS 12.0.0. Agree­
m ent between the various classification systems and 
classification by treating physician was performed using 
MedCalc version 8.0.0.0.
Role o f  funding source
The funding source had no involvement in the study 
design, the collection, analysis, and interpretation of data, 
in the writing of the report, and in the decision to submit 
the paper for publication.
Tab le  1: M odified systems fo r th e  classification o f dengue haem orrhagic fever.
Bleeding and thrombocytopenia 
Bleeding and haemoconcentration 
Haemoconcentration and thrombocytopenia 
Bleeding and thrombocytopenia or haemoconcentration 
Thrombocytopenia and haemoconcentration or bleeding 
Haemoconcentration and bleeding or thrombocytopenia
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Results
A total of 198 patients were initially enrolled in this study. 
Parents from thirteen patients withdrew informed con­
sent during follow up. Two patients appeared not to suffer 
from dengue during follow up (1 patient was diagnosed 
with measles and 1 patient was diagnosed with malaria). 
O f the remaining 183 patients, 28 patients (15%) had 
inconclusive serology and were therefore categorised as 
indeterminate. Three patients (2%) had definitive nega­
tive serology and were categorized as not dengue. The 
presence of dengue was objectively confirmed in 152 
patients (83%): 115 by serology, 21 by dot blot immu­
noassay and 16 by dengue serotype specific reverse tran­
scription PCR (seven Dengue virus serotype-1, four 
Dengue virus serotype-2, four Dengue virus serotype-3 
and one Dengue virus serotype 1). O f the patients with 
confirmed dengue, 66 had evidence of circulatory failure: 
52 (34%) had shock on admission (40 had hypotension, 
2 had a narrow pulse pressure and 10 patients had both 
hypotension and a narrow pulse pressure) and 14 (9%) 
went on to develop shock within 48 hours after admis­
sion. Six patients (4%) died because of prolonged shock, 
massive haemorrhage and respiratory failure. Patient 
characteristics on admission are summarised in Table 2. 
All patients were previously well and had an unremarka­
ble medical history.
Diagnostic a ccuracy o f  the various classification systems
According to the WHO classification system, 20 (13%) 
patients were classified as having DF and 132 (87%) as 
having DHF. O f the DHF group, 57 (43%) could be clas­
sified as having DSS. Of the 66 patients with confirmed 
dengue and circulatory failure, 9 (14%) failed to meet all 
four criteria necessary for a diagnosis of DHF, and were 
thus classified as having DF. Six patients had a negative 
tourniquet test result and no bleeding manifestations dur­
ing hospital admission, 1 patient never had a platelet 
count less than 100.000 cells/mm3, and the remaining 2 
had no evidence of haemoconcentration or other signs of 
plasma leakage. The WHO classification system had a sen­
sitivity of 86% (95%CI 76-94). The number of patients 
with circulatory failure classified as DHF changed when 
the WHO classification system was modified. Interest­
ingly, all modifications had a higher sensitivity than the 
WHO classification system. The sensitivities of the various 
classification systems are shown in Table 3. Eleven 
patients without circulatory failure were classified as hav­
ing DF according to the WHO classification system. Mod­
ification by the various systems came at the expense of 
some DF patients being reclassified as DHF as shown in 
Table 4.
Disease classification by treating physicians
Treating physicians classified 8 patients (5%) as having 
DF and the remaining 144 patients (95%) as having DHF.
Of the 144 patients diagnosed as having DHF, 91 (63%) 
were considered to have circulatory failure at admission or 
at some point in time during admission in the hospital. In 
addition to the 66 patients with hypotension or narrow 
pulse pressure, treating physicians considered 25 patients 
with tachycardia, restlessness and cold and clammy skin 
as having compensated shock and subsequently diag­
nosed them as having circulatory failure. Agreements 
between the various classification systems and disease 
classification by treating physicians are shown in Table 5. 
The WHO classification system and three modified classi­
fication systems showed moderate agreement with classi­
fication by the treating physician: bleeding + 
thrombocytopenia, k w value 0.53 (95% CI 0.41-0.64); 
bleeding + thrombocytopenia or haemoconcentration, k w 
value 0.55 (95% CI 0.43-0.66); WHO classification sys­
tem, k w value 0.57 (95% CI 0.45-0.68); and bleeding + 
haemoconcentration, Kw value 0.59 (95% CI 0.47-0.71). 
The remaining three modified classification systems 
showed good agreement with classification by the treating 
physician: thrombocytopenia + bleeding or haemocon- 
centration, Kw value 0.64 (95% CI 0.53-0.74); throm bo­
cytopenia + haemoconcentration, Kw value 0.67 (95% CI
0.56-0.78); and haemoconcentration + thrombocytope­
nia or bleeding, Kw value 0.70 (95% CI 0.59-0.81).
Discussion
Our results show that a considerable number of dengue 
virus infected patients with circulatory failure is not iden­
tified correctly when the WHO classification system is 
applied. By modifying the combination of criteria that are 
included in the WHO classification system, we were able 
to identify more patients with circulatory failure. Overall, 
86% of patients with circulatory failure were identified 
correctly by the strict WHO classification system. By con­
trast, four modified classification systems recognized 
more than 90% of patients with circulatory failure as 
DHF.
These findings are largely in line with observations made 
by Phuong and colleagues who studied a considerable 
larger group of Vietnamese patients [8]. They also dem on­
strated that all modified classification systems outper­
formed the WHO classification system in the 
identification of 631 patients with confirmed dengue and 
circulatory failure as a reference standard. A high sensitiv­
ity (> 90%) was found with the following modified classi­
fication systems: a haemorrhagic tendency with either 
thrombocytopenia or haemoconcentration (93%), 
haemoconcentration with either thrombocytopenia or a 
haemorrhagic tendency (94%) and thrombocytopenia 
with either haemoconcentration or a haemorrhagic ten­
dency (95%). This comes at the expense of more patients 
being classified as DHF when any of the modified classifi­
cation systems is used compared to the WHO classifica­
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Tab le  2: Baseline characteristics a t admission o f patients w ith  confirm ed acute dengue.*
Variable All patients (n = 152) Fatal cases (n = 6)
Age in years, median (IQR) 7 (5 -10) 4 (4 -6)
Male sex, n (%) 74 (49) 5 (83)
Duration of illness in days, median (IQR) 4 (3 -4) 4 (4 -5)
Haemorrhagic tendency, n (%) ^ 133 (88) 6 (100)
Positive tourniquet test, n (%) 103 (68) 3 (50)
Spontaneous haemorrhage, n (%) £ 93 (61) 6 (100)
Hepatomegaly, n (%) 105 (69) 6 (100)
Systolic blood pressure in mmHg, median 90 (80-100) 85 (68-93)
(IQR)
Hypotension for age, n (%) f 50 (33) 2 (33)
Pulse pressure <20 mmHg, n (%) 12 (8) 6 (100)
Pulse rate in beats/min, median (IQR) 120 (104-128) 130 (120-149)
Presence of pleural effusion, n (%) ¿ 102 (67) 5 (83)
Haematocrit in %, median (IQR) 41 (36-45) 42 (35-47)
Platelet count in cells/mm3, median (IQR) 58.000 (37.000-85.000) 31.000 (27.000-76.000)
Platelet count < 100.000 cells/mm3, n (%) 131 (86) 5 (83)
*  n, denotes number; IQR, denotes interquartile range
^ haemorrhagic tendency was present when at least one of the following was present: a) positive tourniquet test, b) petechiae, ecchymoses or 
purpura, c) bleeding from the mucosa, gastrointestinal tract, injection sites or other locations, d) haematemesis or melena 
£ spontaneous haemorrhage was defined as all haemorrhagic manifestations not caused by a tourniquet test or venapuncture 
f  hypotension is defined to  be a systolic pressure of <80 mmHg for those <5 years of age, or <90 mmHg for those > 5 years [2]
¿ the presence of pleural effusion was assessed through a chest X-ray
tion system. However, if the purpose of classifying dengue 
disease severity is to identify the maximum number of 
patients with circulatory failure, then it would seem, that 
on the basis of Phuong's and our results, one of these 
modified classification systems is to be preferred.
Likewise, we found that the WHO classification system 
was in only modest agreement with the intuitive classifi­
cation by treating physicians. Treating physicians were 
inclined to classify patients with evidence of plasma leak­
age as having DHF even in the absence of both throm bo­
cytopenia and a haemorrhagic tendency. As a result, the 
modified classification systems haemoconcentration and 
thrombocytopenia, and haemoconcentration with either 
thrombocytopenia or a haemorrhagic tendency dem on­
strated good agreement with the intuitive classification by 
treating physicians. Phuong and colleagues noted that in 
clinical practice many physicians use the modified system 
of a haemorrhagic tendency usually together with throm ­
bocytopenia rather than haemoconcentration. We 
showed that this does no t hold true for our study setting. 
Treating physicians were inclined to classify severe cases as 
suffering from DHF using a combination of haemocon- 
centration with either thrombocytopenia or a haemor- 
rhagic tendency instead of a haemorrhagic tendency 
together with thrombocytopenia.
Although several modified classification systems were in 
good agreement with the intuitive classification by treat­
ing physician, they still did not reach the magnitude of
Tab le  3: Sensitivity o f th e  various disease classification systems in 152 patients w ith  confirm ed acute dengue virus in fection .*
Criteria used for the classification of DHF Number of patients with circulatory failure (n = Sensitivity (95% CI)
patients 66) classified as DHF
W H O  classification system 
Bleeding and thrombocytopenia 
Bleeding and haemoconcentration 
Haemoconcentration and Thrombocytopenia 
Bleeding and thrombocytopenia or 
haemoconcentration
Thrombocytopenia and haemoconcentration 
or bleeding
Haemoconcentration and bleeding or 
thrombocytopenia









fever; DHF, denotes dengue haemorrhagic fever; W H O , denotes W orld
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Tab le  4: P roportion  o f patients w ith o u t c ircu lato ry fa ilure and classified as D F according to  W H O  crite ria , th a t is reclassified to  D H F  
when th e  various m odified classification systems are applied.*
Criteria used for the classification of DHF patients Number of DF patients without circulatory failure reclassified to Proportion (95% CI)
DHF
Bleeding and thrombocytopenia 
Bleeding and haemoconcentration 
Haemoconcentration and Thrombocytopenia 
Bleeding and thrombocytopenia or haemoconcentration 
Thrombocytopenia and haemoconcentration or bleeding 
Haemoconcentration and Bleeding or thrombocytopenia
5 45 (17-77)
1 9 (0- 4 1)
2 18 (2 -52)
6 55 (23-83)
7 64 (31-89)
3 27 (6 -61)
; DF, denotes dengue fever; DHF, denotes dengue haemorrhagic fever; W H O , denotes W orld  Health Organization.
agreement we had expected (maximum Kw value 0.70). 
Two separate views of treating physicians played a promi­
nent part in this. First, a considerable num ber of patients 
were classified as shock, although they did not meet the 
WHO criteria for shock. Treating physicians classified 
patients as having shock when symptoms and signs, such 
as cool and clammy skin, rapid pulse, decreased urinary 
output and confusion, indicating a stage I or compensated 
shock were present. This was done even in the absence of 
hypotension for age or a narrow pulse pressure. Second, 
patients who had no evidence of plasma leakage bu t did 
have a haemorrhagic tendency and thrombocytopenia 
were classified as DF. However, when circulatory failure 
was present a classification of DSS was given. To make a 
distinction between patients with and without evidence of
plasma leakage an additional classification could be use­
ful [4,5].
Several potential limitations of this study should be 
noted. First, grading of dengue disease severity was per­
formed at the time of discharge or after completion of the 
study. By determining disease severity retrospectively, the 
classification systems may only serve a limited num ber of 
purposes. For example, they may be used to collect public 
health data on incidence of severe disease in different 
locations or over time. The classification systems are not 
suited for the identification of those at risk for developing 
severe disease, bu t they can be used as outcomes of inter­
est in clinical trials and observational studies focusing on 
for example risk factors that may predict poor outcome.
Tab le  5: A g re e m e n t betw een th e  various classification systems and classification by th e  trea tin g  physician.*
Classification by treating physician
DSS DHF DF
W H O  classification system DSS 57 0 0
DHF 23 52 0
DF 1 1 1 8
Bleeding and thrombocytopenia DSS 59 0 0
DHF 23 52 5
DF 9 1 3
Bleeding and haemoconcentration DSS 58 0 0
DHF 23 53 0
DF 10 0 8
Haemoconcentration and thrombocytopenia DSS 63 0 0
DHF 25 52 0
DF 3 1 8
Bleeding and thrombocytopenia or haemoconcentration DSS 60 0 0
DHF 23 53 5
DF 8 0 3
Thrombocytopenia and haemoconcentration or bleeding DSS 65 0 0
DHF 25 52 5
DF 1 1 3
Haemoconcentration and bleeding or thrombocytopenia DSS 64 0 0
DHF 25 53 0
DF 2 0 8
*  DF, denotes dengue fever; DHF, denotes dengue haemorrhagic fever; DSS, denotes dengue shock syndrome; W H O , denotes W orld  Health 
Organization.
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Second, patients' clinical course was assessed daily using 
standard data forms, regular haematocrit and throm bo­
cyte measurements and additional diagnostic testing (i.e. 
chest radiography). This enabled us to collect all the data 
necessary for classification of disease severity. If regular 
laboratory testing or additional diagnostic tests are not 
performed because of for example limited resources, it 
may be difficult to demonstrate the presence of haemo­
concentration with the possibility of misclassification. In 
addition, one can elaborate on the use of ultrasound in 
the detection of evidence of plasma leakage. We did not 
perform an ultrasound scan of the chest and/or abdomen 
because of practical issues. In several patients with circula­
tory failure, no evidence of plasma leakage was found 
despite the use of a chest radiography and frequent meas­
urement of haematocrit (at admission, every 2 hours for 
the first 6 hours and than every 6 hours until stable). 
Whether ultrasound would have provided additional 
cases with evidence of plasma leakage, is uncertain but 
theoretically possible. Several studies reported on the use 
of ultrasound in determining the presence of pleural effu­
sion, ascites or thickening of the gallbladder wall [16-19]. 
Although small amounts of abdominal and pericardial 
effusions can be detected using ultrasonography, its supe­
riority over a combination of chest radiography and fre­
quent measurement of haematocrit has not been 
demonstrated thus far. Finally, our analysis was confined 
to Javanese patients. As far as we know, only one other 
study performed in a Vietnamese population assessed the 
same modifications [8]. We can therefore only speculate 
on the possibility of extrapolating our findings to popula­
tions originating from other dengue affected areas like for 
example the American region.
An increasing number of dengue infections have been 
related to other unusual manifestations. These include 
fulminant liver failure, cardiomyopathy, ocular manifes­
tations and neurological phenom ena such as altered con­
sciousness, convulsions, and coma resulting from 
encephalitis and encephalopathy [1,20-23]. Neurological 
manifestations were initially ascribed to complications 
secondary to DHF and DSS, although recently the inva­
sion of the central nervous system by dengue viruses has 
been suggested [23]. Patients with symptoms or signs of a 
suspected infection of the central nervous system were not 
considered for inclusion in our study nor was additional 
diagnostic testing (i.e. lumbar puncture) done in included 
patients with m inor neurological symptoms. We are 
therefore unable to pronounce upon the possibility of an 
increase in patients with encephalitis caused by dengue 
viruses. If additional studies show that such is the case 
than this would highlight the fact that the WHO classifi­
cation needs revision.
Conclusion
In conclusion, our results show that the WHO classifica­
tion system is less accurate in correctly classifying dengue 
disease severity than all other modified classification sys­
tems. The implication of these findings is to question the 
use of the strict WHO classification system to classify den­
gue disease severity, all the more because it lacks sufficient 
agreement with how patients are classified in clinical prac­
tice. Additional research is needed in order to refine and 
improve the clinical usefulness of the system.
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